Fecal matter transplantation and cognition: a systematic review in Alzheimer’s disease and related disorders
Preliminary evidence suggests FMT may have cognitive benefits in AD patients and recurrent CDI. However, the limited number of studies and the presence of CDI as a common comorbidity highlight the need for larger, controlled trials to better define its role in AD management.
Authors
- Isabela Alicia Fink
- GABRIELLE GUINDANI MAIA
- Gabriela Bezerra Sorato (ORCID: https://orcid.org/0009-0004-5798-9689)
- Maria Fernanda Peruci Felippe
- Jessica Vargas Lopes
- Laura Carolina Nardi Motta
- Leonardo Bedatti Koehler
- Ana Carolina Gomes Petry
- Daniel Pasini Gonçalves
- Matias Pinheiro de Macêdo Neto
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Universidade Luterana do Brasil (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_107684
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00